基层医疗提供者参与甲状腺癌生存者照护的现状
本研究调查了来自乔治亚州和洛杉矶SEER登记处的甲状腺癌患者所确定的基层医疗提供者(PCPs),了解其在甲状腺癌生存者照护中的参与度和信心。结果显示76%的PCPs参与长期监测,但处理生存者照护的信心存在不足;参与度与将临床指南作为最有影响力来源相关(OR 4.29;95% CI,1.56-11.82)。
要点
- 76%的PCPs报告参与甲状腺癌长期监测。
- 将临床指南视为最有影响力来源的PCPs参与度更高(OR 4.29;95% CI,1.56-11.82)。
- PCPs在处理生存者照护各方面的信心存在差异,从14%到39%不等。
核心结论
- PCPs报告参与长期监测,但在处理生存者照护方面的信心仍存在差距。
- 明确PCP角色的甲状腺癌生存者指南是提高其参与信心的一个机会。
研究设计与样本
- 研究调查了由乔治亚州和洛杉矶SEER登记处的甲状腺癌患者确定的PCPs(n=162,应答率56%)。
主要发现
- 76%的PCPs报告参与长期监测。
- 将临床指南视为最有影响力来源的PCPs参与度更高(OR 4.29;95% CI,1.56-11.82)。
- PCPs报告高信心处理生存者照护的比例因方面而异:转诊患者至专科医生39%,颈部超声的作用36%,随机甲状腺球蛋白水平的作用27%,结束长期监测14%。
- 参与监测的PCPs更可能报告高信心讨论随机甲状腺球蛋白水平的作用(33.3% vs 未参与7.9%;P < 0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: While prior research has examined how primary care providers (PCPs) can care for breast and colon cancer survivors, little is known about their role in thyroid cancer survivorship. OBJECTIVE: To understand PCP involvement and confidence in thyroid cancer survivorship care. DESIGN/SETTING/PARTICIPANTS: We surveyed PCPs identified by thyroid cancer patients from the Georgia and LA SEER registries (n = 162, response rate 56%). PCPs reported their involvement in long-term surveillance and confidence in handling survivorship care (role of random thyroglobulin levels and neck ultrasound, and when to end long-term surveillance and refer back to the specialist). We examined: 1) PCP-reported factors associated with involvement using multivariable analyses; and 2) bivariate associations between involvement and confidence in handling survivorship care. MAIN OUTCOME MEASURES: PCP involvement (involved vs not involved) and confidence (high vs low). RESULTS: Many PCPs (76%) reported being involved in long-term surveillance. Involvement was greater among PCPs who noted clinical guidelines as the most influential source in guiding treatment (OR 4.29; 95% CI, 1.56-11.82). PCPs reporting high confidence in handling survivorship varied by aspects of care: refer patient to specialist (39%), role of neck ultrasound (36%) and random thyroglobulin levels (27%), and end long-term surveillance (14%). PCPs reporting involvement were more likely to report high confidence in discussing the role of random thyroglobulin levels (33.3% vs 7.9% not involved; P < 0.01). CONCLUSIONS: While PCPs reported being involved in long-term surveillance, gaps remain in their confidence in handling survivorship care. Thyroid cancer survivorship guidelines that delineate PCP roles present one opportunity to increase confidence about their participation.
引用
- Radhakrishnan A, Reyes-Gastelum D, Gay B, et al. Primary Care Provider Involvement in Thyroid Cancer Survivorship Care. J Clin Endocrinol Metab. 2020. PMID: 32639557. doi:10.1210/clinem/dgaa437
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。